|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Thyrotropin Receptor Antibody, Serum
Test CodeAlias/See Also
Antibodies to TSH receptor
Inhibitory Immunoglobulin
Long-Acting Thyroid Stimulator (LATS)
TBII (TSH-Binding Inhibiting Immunoglobulin)
Thyroid-Stimulating Hormone Receptor (TSH Receptor) Antibody
TRAb (Thyrotropin Receptor Antibody)
TSH (Thyroid-Stimulating Hormone) Receptor Binding
TSH Binding Inhibition Index
TSH Receptor (Thyroid-Stimulating Hormone Receptor) Antibody
TSH-Binding Inhibiting Immunoglobulin (TBII)
CPT Codes
83520
Preferred Specimen
2.0 mL of whole blood or 1.0 mL of serum
Minimum Volume
1.0 mL of whole blood or 0.5 mL of serum
Transport Container
Transport Temperature
Specimen Stability
Refrigerated: 7 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Methodology
Electrochemiluminescence Immunoassay
Setup Schedule
Report Available
Reference Range
< or =1.75 IU/L
Clinical Significance
Recommended first-line test for detection of thyrotropin receptor (TSHR) antibodies, and used in the following situations:
-Differential diagnosis of etiology of thyrotoxicosis in patients with ambiguous clinical findings and/or contraindicated (eg, pregnant or breast-feeding) or nondiagnostic thyroid radioisotope scans
-Diagnosis of clinically suspected Graves disease (eg, extrathyroidal manifestation of Graves disease include endocrine exophthalmos, pretibial myxedema, thyroid acropachy) in patients with normal thyroid function tests
-Determining the risk of neonatal thyrotoxicosis in a fetus of a pregnant female with active or past active Graves disease
-Differential diagnosis of gestational thyrotoxicosis versus first trimester manifestation or recurrence of Graves disease
-Assessing the risk of Graves disease relapse after antithyroid drug treatment